MLMelanie R. Lovell

Melanie R. Lovell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melanie R. Lovell has a total of 218 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Australian Pathways for Specialist Pain Management and Early Palliative Care for People With Pancreatic Cancer: Developed Using a Community Consensus Approach

    by Jennifer Philip, Melanie R. Lovell, Kylee Bellingham, Gail Garvey, Gregory B. Crawford, Nicole M. Rankin, Kara Burns, Isabel Young, Vivienne Milch, Dorothy Keefe, et al.

    Introduction: Despite evidence of improved outcomes, people with pancreatic cancer have highly variable access to effective pain relief and palliative care. We aimed to develop evidence‐based, community‐informed standardised pathways to timely pain management and early palliative care for people with pancreatic cancer. Main Recommendations: Using a multi‐method, comprehensive, community engagement and evidence‐informed approach, we developed pathways to standardise referral to pain management and early palliative care for people with pancreatic cancer. Community engagement included representation from multidisciplinary clinicians, community groups and people with lived experience from across regions and all Australian states. We developed two pathways: (i) a pathway for pain management for people with resectable pancreatic cancer and (ii) an integrated pathway for pain management and palliative care for people with unresectable pancreatic cancer ( https://www.pancare.org.au/pancreatic‐cancer‐roadmap‐projects/pancreatic‐cancer‐pathways ). Clinical guidance providing practical steps and links to evidence accompany the pathways. Key elements of the pathways included: screening for pain at each encounter, comprehensive holistic assessment and management; early consideration of interventional pain management in the event of refractory pain; introduction of palliative care at time of diagnosis of metastatic or unresectable pancreatic cancer with links to suggested language to address potential community hesitancy; and recommendation to discuss referrals for palliative care and interventional pain management at cancer multidisciplinary meetings. Changes in Management as a Result of the Guidelines: The pathways developed have set forth best practice standards grounded in evidence and expert consensus. The extensive clinical and community engagement ensures the relevance and ownership of these pathways. Implementation of the pathways will reduce existing variation in access and enhance the quality of care for people with pancreatic cancer. Furthermore, the pathways offer an opportunity to benchmark practice within and between services.

  • Update of the Australian Guideline for the Management of Cancer Pain in Adults

    by Melanie R. Lovell, Farwa Rizvi, Tim Luckett, Meera Agar, Jane L. Phillips, Frances M. Boyle, John Stubbs, Tim Hucker, Roopa Gawarikar, Christina Abdel Shaheed, et al.

    Aims: The Cancer Council Australia Cancer Pain Management in Adults Clinical Guideline aimed to inform timely, evidence‐based guidance for managing cancer‐related pain. Methods: The ADAPTE approach for guideline updates was adopted. Source guidelines were selected following the AGREE II criteria. The target population was adults with chronic cancer‐related pain. The interventions were screening, assessment, and management of cancer‐related pain. Target users and settings were all health professionals caring for adults with cancer in any healthcare setting. Outcomes are reduction in cancer‐related pain. Results: Recommendations were mostly adopted directly from source guidelines and the recommendation strength reflected those of the source guidelines. Those which were developed de novo were either based on Level 1 evidence or consensus within the context of a documented need in the Australian setting. Conclusions: The Cancer Council Australia guideline for managing cancer pain in adults contains evidence‐based recommendations to guide appropriate evidence‐based care.

  • Open Access

    Lidocaine for Neuropathic Cancer Pain (LiCPain): A Pilot Randomized Controlled Trial

    by Jessica T. Lee, Melanie R. Lovell, Megan Ritchie, Belinda E. Butcher, Caitlin Sheehan, Belinda Fazekas, Andrew McLachlan, Nikki McCaffrey, Jane L. Phillips, Anthony Linton, et al.


  • Spirituality and Pain Management in Palliative Care

    by Philip D. Austin, Melanie R. Lovell

  • Pain and Pain Management in Palliative Care

    by Abigail E. Franklin, Melanie R. Lovell

  • Open Access

    How can HCI support end-of-life care? Critical perspectives on sociotechnical imaginaries for palliative care

    by Naseem Ahmadpour, Phillip Gough, Melanie Lovell, Philip Austin, Philip Poronnik, Wendy Qi Zhang, Judy Kay, Bob Kummerfeld, Tim Luckett, Martin Brown, et al.

    Designing technologies in the palliative care environment is difficult due to the sensitivity of the context and vulnerability of the patients and their families in a critical stage of life. We conducted two focus groups with 9 healthcare workers to capture sociotechnical imaginaries to support physical, psychological, social and spiritual aspects of the patient care in the palliative environment. The findings reveal recurring themes of care: expressing respect in safe spaces, transitioning into the unknown and experiencing home again, taking opportunities for uplifting care, communication for empowerment and risk mitigation, and connection to support networks. These are discussed through a lens of the materiality of care provided to patients, where tangible materials of care are entwined with patients’ values and culture. This in turn offers insight into opportunities for palliative care technology.


  • Open Access

    Treatment patterns and out-of-hospital healthcare resource utilisation by patients with advanced cancer living with pain: An analysis from the Stop Cancer PAIN trial

    by Nikki McCaffrey, Seong Leang Cheah, Tim Luckett, Jane L Phillips, Meera Agar, Patricia M Davidson, Frances Boyle, Tim Shaw, David C Currow, Melanie Lovell

    Background: About 70% of patients with advanced cancer experience pain. Few studies have investigated the use of healthcare in this population and the relationship between pain intensity and costs.Methods: Adults with advanced cancer and scored worst pain ≥ 2/10 on a numeric rating scale (NRS) were recruited from 6 Australian oncology/palliative care outpatient services to the Stop Cancer PAIN trial (08/15-06/19). Out-of-hospital, publicly funded services, prescriptions and costs were estimated for the three months before pain screening. Descriptive statistics summarize the clinico-demographic variables, health services and costs, treatments and pain scores. Relationships with costs were explored using Spearman correlations, Mann-Whitney U and Kruskal-Wallis tests, and a gamma log-link generalized linear model.Results: Overall, 212 participants had median worst pain scores of five (inter-quartile range 4). The most frequently prescribed medications were opioids (60.1%) and peptic ulcer/gastro-oesophageal reflux disease (GORD) drugs (51.6%). The total average healthcare cost in the three months before the census date was A$6,742 (95% CI $5,637, $7,847), approximately $27,000 annually. Men had higher mean healthcare costs than women, adjusting for age, cancer type and pain levels (men $7,872, women $4,493, p<0.01) and higher expenditure on prescriptions (men $5,559, women $2,034, p<0.01).Conclusions: In this population with pain and cancer, there was no clear relationship between healthcare costs and pain severity. These treatment patterns requiring further exploration including the prevalence of peptic ulcer/GORD drugs, and lipid lowering agents and the higher healthcare costs for men.Trial registration: ACTRN12615000064505. World Health Organisation unique trial numberU1111–1164–4649. Registered 23 January 2015.


  • Open Access

    Australian residential aged care home staff experiences of implementing an intervention to improve palliative and end‐of‐life care for residents: A qualitative study

    by Srivalli Vilapakkam Nagarajan, Christopher J. Poulos, Josephine M. Clayton, Mustafa Atee, Thomas Morris, Melanie R. Lovell

    Access to high‐quality and safe evidence‐based palliative care (PC) is important to ensure good end‐of‐life care for older people in residential aged care homes (RACHs). However, many barriers to providing PC in RACHs are frequently cited. The Quality End‐of‐Life Care (QEoLC) Project was a multicomponent intervention that included training, evidence‐based tools and tele‐mentoring, aiming to equip healthcare professionals and careworkers in RACHs with knowledge, skills and confidence in providing PC to residents. This study aims to understand: (1) the experiences of healthcare professionals, careworkers, care managers, planners/implementers who participated in the implementation of the QEoLC Project; and (2) the barriers and facilitators to the implementation. Staff from two RACHs in New South Wales, Australia were recruited between September to November 2021. Semi‐structured interviews and thematic data analysis were used. Fifteen participants (seven health professionals [includes one nurse, two clinical educators, three workplace trainers, one clinical manager/nurse], three careworkers and five managers) were interviewed. Most RACH participants agreed that the QEoLC Project increased their awareness of PC and provided them with the skills/confidence to openly discuss death and dying. Participants perceived that the components of the QEoLC Project had the following benefits for residents: more appropriate use of medications, initiation of timely pain management and discussions with families regarding end‐of‐life care preferences. Key facilitators for implementation were the role of champions, the role of the steering committee, regular clinical meetings to discuss at‐risk residents and mentoring. Implementation barriers included: high staff turnover, COVID‐19 pandemic, time constraints, perceived absence of executive sponsorship, lack of practical support and systems‐related barriers. The findings underline the need for strong leadership, supportive organisational culture and commitment to the implementation of processes for improving the quality of end‐of‐life care. Furthermore, the results highlight the need for codesigning the intervention with RACHs, provision of dedicated staff/resources to support implementation, and integration of project tools with existing systems for achieving effective implementation outcomes.